CRYO-CELL INTERNATIONAL, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $1.69 million for the 3-month period ending 2018-02-28, per its 10-Q filed 2018-04-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2018-04-16
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-02-28 was $1.69M, a 294.32% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-11-30 was $2.11M, a 17.61% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-08-31 was $1.22M, a 13.33% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-05-31 was $1.95M, a 57.11% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was $5.72M, a 14.64% increase from fiscal 2016.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was $4.99M, a 2.81% increase from fiscal 2015.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was $4.85M, a 212.03% increase from fiscal 2014.
- CRYO-CELL INTERNATIONAL, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was $1.55M, a 89.16% increase from fiscal 2013.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-02-28 | $1.69M 10-Q · filed 2018-04-16 | $3.80M derived: sum of 2 quarters · filed 2018-04-16 | $5.03M derived: sum of 3 quarters · filed 2018-04-16 | $6.98M derived: sum of 4 quarters · filed 2018-04-16 |
| 2017-11-30 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $3.34M derived: sum of 2 quarters · filed 2018-02-28 | $5.29M derived: sum of 3 quarters · filed 2018-02-28 | $5.72M 10-K · filed 2018-02-28 |
| 2017-08-31 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-16 | $3.18M derived: sum of 2 quarters · filed 2017-10-16 | $3.61M 10-Q · filed 2017-10-16 | $6.17M derived: sum of 4 quarters · filed 2018-04-16 |
| 2017-05-31 | $1.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-07 | $2.38M 10-Q · filed 2017-07-07 | $4.95M derived: sum of 3 quarters · filed 2018-04-16 | $6.03M derived: sum of 4 quarters · filed 2018-04-16 |
| 2017-02-28 | $429.06K 10-Q · filed 2018-04-16 | $2.99M derived: sum of 2 quarters · filed 2018-04-16 | $4.07M derived: sum of 3 quarters · filed 2018-04-16 | $5.32M derived: sum of 4 quarters · filed 2018-04-16 |
| 2016-11-30 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $3.64M derived: sum of 2 quarters · filed 2018-02-28 | $4.89M derived: sum of 3 quarters · filed 2018-02-28 | $4.99M 10-K · filed 2018-02-28 |
| 2016-08-31 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-16 | $2.32M derived: sum of 2 quarters · filed 2017-10-16 | $2.42M 10-Q · filed 2017-10-16 | $4.41M derived: sum of 4 quarters · filed 2017-10-16 |
| 2016-05-31 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-11 | $1.34M 10-Q · filed 2017-07-07 | $3.33M derived: sum of 3 quarters · filed 2017-04-13 | $4.36M derived: sum of 4 quarters · filed 2017-04-13 |
| 2016-02-29 | $101.42K 10-Q · filed 2017-04-13 | $2.09M derived: sum of 2 quarters · filed 2017-04-13 | $3.12M derived: sum of 3 quarters · filed 2017-04-13 | $4.62M derived: sum of 4 quarters · filed 2017-04-13 |
| 2015-11-30 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $3.02M derived: sum of 2 quarters · filed 2017-02-28 | $4.52M derived: sum of 3 quarters · filed 2017-02-28 | $4.85M 10-K · filed 2017-02-28 |
| 2015-08-31 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-17 | $2.53M derived: sum of 2 quarters · filed 2016-10-17 | $2.86M 10-Q · filed 2016-10-17 | $3.11M derived: sum of 4 quarters · filed 2016-10-17 |
| 2015-05-31 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-11 | $1.83M 10-Q · filed 2016-07-11 | $2.07M derived: sum of 3 quarters · filed 2016-07-11 | $3.02M derived: sum of 4 quarters · filed 2016-07-11 |
| 2015-02-28 | $328.96K 10-Q · filed 2016-04-14 | $572.05K derived: sum of 2 quarters · filed 2016-04-14 | $1.52M derived: sum of 3 quarters · filed 2016-04-14 | $1.99M derived: sum of 4 quarters · filed 2016-04-14 |
| 2014-11-30 | $243.09K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.19M derived: sum of 2 quarters · filed 2016-02-29 | $1.66M derived: sum of 3 quarters · filed 2016-02-29 | $1.55M 10-K · filed 2016-02-29 |
| 2014-08-31 | $949.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-15 | $1.42M derived: sum of 2 quarters · filed 2015-10-15 | $1.31M 10-Q · filed 2015-10-15 | $1.29M derived: sum of 4 quarters · filed 2015-10-15 |
| 2014-05-31 | $468.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-15 | $361.76K 10-Q · filed 2015-07-15 | $339.91K derived: sum of 3 quarters · filed 2015-07-15 | $94.34K derived: sum of 4 quarters · filed 2015-07-15 |
| 2014-02-28 | -$106.70K 10-Q · filed 2015-04-14 | -$128.54K derived: sum of 2 quarters · filed 2015-03-02 | -$374.11K derived: sum of 3 quarters · filed 2015-03-02 | $209.61K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-11-30 | -$21.84K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$267.42K derived: sum of 2 quarters · filed 2015-03-02 | $316.31K derived: sum of 3 quarters · filed 2015-03-02 | $821.98K 10-K · filed 2015-03-02 |
| 2013-08-31 | -$245.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-15 | $338.15K derived: sum of 2 quarters · filed 2014-10-15 | $843.83K 10-Q · filed 2014-10-15 | |
| 2013-05-31 | $583.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-03 | $1.09M 10-Q · filed 2014-07-03 | ||
| 2013-02-28 | $505.68K 10-Q · filed 2014-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |